Detail akcie Amoeba online

Business Summary: Amoeba SA is a France-based company that develops, manufactures and markets biological products. The Company specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The Company's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The Company is engaged in various technical, commercial, industrial and investment partnerships.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Amoeba SA revenues was not reported. Net loss applicable to common stockholders increased 25% to EUR3.9M. Higher net loss reflects Sales of Services segment loss increase of 15% to EUR3.1M, France segment loss increase of 15% to EUR3.1M. Basic Earnings per Share excluding Extraordinary Items decreased from -EUR0.07 to -EUR0.08.